Xapavir-LT Tablet (30’s) is a combination medication designed to treat HIV (Human Immunodeficiency Virus) infection. It contains three active ingredients: Dolutegravir (50mg), Lamivudine (300mg), and Tenofovir (300mg). Dolutegravir is an integrase strand transfer inhibitor that prevents the virus from integrating its genetic material into the host’s DNA, while Lamivudine and Tenofovir are nucleoside reverse transcriptase inhibitors that block the reverse transcription process, thereby inhibiting viral replication. This powerful combination works synergistically to reduce the viral load in the body, helping to maintain immune function and prevent the progression to AIDS (Acquired Immunodeficiency Syndrome). Xapavir-LT is typically prescribed as part of a comprehensive HIV treatment regimen and is taken orally, making it a convenient option for patients managing this chronic condition. The tablet is well-tolerated and has been shown to improve the quality of life for individuals living with HIV.